The operational environment of the Generic Peptides Market is shaped by complex intellectual property frameworks and intense patent litigation dynamics between generic entrants and original brand developers. Brand-name pharmaceutical companies frequently construct intricate patent walls around their blockbuster peptide drugs, protecting not just the core amino acid sequence, but also specific...